Clinical Trial Update: The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin

View source ↗

Summary

Terminated clinical trial evaluating the impact of adherence to oral semaglutide on glycemic control in people with type 2 diabetes treated with metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rybelsus (semaglutide)

Snippet

Sponsor: Aalborg University Hospital | Conditions: Diabetes Mellitus, Type 2 | Status: TERMINATED